Matej Mikulic
Research expert covering health, pharma & medtech
Chinese COVID-19 vaccines - statistics & facts
The COVID-19 pandemic poses a critical challenge to people’s well-being worldwide. As a powerful weapon to reduce the spread of the virus and save lives, vaccination is often seen as a vital solution to mitigate the burdens posed by COVID-19 and potentially end the pandemic for good. As the first country impacted by the pandemic, China was one of the pioneers in the virological research on SARS-CoV-2. Chinese pharmaceutical enterprises were also among the first companies that successfully developed effective vaccines against the disease. Thanks to the country’s substantial production capacity, Chinese COVID-19 vaccines successfully fulfilled the needs of the domestic market, contributing to the country’s massive vaccination campaign. They were also widely adopted globally, notably in lower and middle-income countries. The strong global demands greatly improved the performance of China’s major vaccine manufacturers, with Sinovac reporting an increase of over 22,000 percent in its annual net income between 2019 and 2021.
